Precigen Inc. (PGEN)
4.82
+0.09 (1.90%)
Upcoming Events
Latest Headlines
Precigen receives FDA orphan drug exclusivity for PAPZIMEOS through 2032
June 15, 2026 6:41 AM - StreetInsider
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
June 15, 2026 6:41 AM - StreetInsider
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices
June 11, 2026 8:00 AM - PR NewsWire
H.C. Wainwright Reiterates Buy Rating on Precigen Inc. (PGEN)
June 2, 2026 6:57 AM - StreetInsider
Form 4 PRECIGEN, INC. For: May 28 Filed by: Thomasian Harry Jr.
June 1, 2026 4:29 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 28 Filed by: Tennant Phil
June 1, 2026 4:29 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 28 Filed by: Shah Rutul R
June 1, 2026 4:27 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 28 Filed by: Lehr Donald P.
June 1, 2026 4:27 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 28 Filed by: Sabzevari Helen
June 1, 2026 4:26 PM - SEC Filing
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
May 30, 2026 2:30 PM - PR NewsWire
Precigen Inc. (PGEN) PT Raised to $14 at H.C. Wainwright
May 28, 2026 7:07 AM - StreetInsider
Form 4 PRECIGEN, INC. For: May 23 Filed by: Thomasian Harry Jr.
May 27, 2026 8:26 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 23 Filed by: Tennant Phil
May 27, 2026 8:24 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 23 Filed by: Shah Rutul R
May 27, 2026 8:21 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 23 Filed by: Sabzevari Helen
May 27, 2026 8:18 PM - SEC Filing
Form 4 PRECIGEN, INC. For: May 23 Filed by: Lehr Donald P.
May 27, 2026 8:15 PM - SEC Filing
Precigen gets seven-year US exclusivity for rare disease drug PAPZIMEOS
May 27, 2026 7:02 AM - StreetInsider
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
May 27, 2026 7:00 AM - PR NewsWire
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026 8:05 AM - PR NewsWire
Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 4:40 PM - SEC Filing
Precigen Inc. (PGEN) PT Raised to $11 at H.C. Wainwright
May 14, 2026 6:42 AM - StreetInsider
Precigen Inc. (PGEN) PT Raised to $11 at Citizens on Above Estimate Q1 Results
May 14, 2026 4:52 AM - StreetInsider
Precigen Inc. (PGEN) Tops Q1 EPS by 1c
May 13, 2026 4:24 PM - StreetInsider
Form 8-K PRECIGEN, INC. For: May 13
May 13, 2026 4:22 PM - SEC Filing
Form 10-Q PRECIGEN, INC. For: Mar 31
May 13, 2026 4:21 PM - SEC Filing
Precigen Reports First Quarter 2026 Financial Results and Business Updates
May 13, 2026 4:05 PM - PR NewsWire
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13
May 7, 2026 4:05 PM - PR NewsWire
Form ARS PRECIGEN, INC. For: Dec 31
April 30, 2026 4:13 PM - SEC Filing
Form DEFA14A PRECIGEN, INC.
April 30, 2026 4:12 PM - SEC Filing
Form DEF 14A PRECIGEN, INC. For: Jun 18
April 30, 2026 4:10 PM - SEC Filing
Form 4 PRECIGEN, INC. For: Apr 20 Filed by: Lehr Donald P.
April 22, 2026 4:24 PM - SEC Filing
Form 4 PRECIGEN, INC. For: Apr 20 Filed by: Sabzevari Helen
April 22, 2026 4:24 PM - SEC Filing
Form 4 PRECIGEN, INC. For: Apr 20 Filed by: Shah Rutul R
April 22, 2026 4:22 PM - SEC Filing
Form 4 PRECIGEN, INC. For: Apr 20 Filed by: Tennant Phil
April 22, 2026 4:20 PM - SEC Filing
Form 4 PRECIGEN, INC. For: Apr 20 Filed by: Thomasian Harry Jr.
April 22, 2026 4:20 PM - SEC Filing
Precigen expects first quarter revenue to exceed $18 million
April 7, 2026 7:01 AM - StreetInsider
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
April 7, 2026 7:00 AM - StreetInsider
Form 4 PRECIGEN, INC. For: Mar 26 Filed by: KIRK RANDAL J
March 31, 2026 4:11 PM - SEC Filing
Form SCHEDULE 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J
March 31, 2026 4:02 PM - SEC Filing
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
March 30, 2026 5:39 PM - SEC Filing
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
March 30, 2026 8:30 AM - PR NewsWire
Precigen Inc. (PGEN) PT Raised to $10 at H.C. Wainwright
March 26, 2026 6:42 AM - StreetInsider
Precigen Inc. (PGEN) PT Raised to $9 at Citizens- PAPZIMEOS Can Dominate RRP Market
March 26, 2026 4:52 AM - StreetInsider
Form 10-K PRECIGEN, INC. For: Dec 31
March 25, 2026 4:54 PM - SEC Filing
Form 8-K PRECIGEN, INC. For: Mar 25
March 25, 2026 4:53 PM - SEC Filing
Precigen Reports Full Year 2025 Financial Results and Business Updates
March 25, 2026 4:05 PM - PR NewsWire
Full Article List
